Initially identified as a target gene of AHR, we now know that PARP7 interacts with many other transcription factors, which regulate various physiological processes and are implicated in cancer, making PARP7 an attractive target for the development of novel therapeutics. The gene discussed is TIPARP; the disease is cancer.